T11	Subject 106 181	children with increased-risk ALL or stage III and IV lymphoblastic lymphoma
T12	Treatment 59 102	HD IV MTX and intrathecal injections of MTX
T10	Age 106 114	children
T15	Treat-Disorder 14 25	CNS relapse
T16	Sub-Disorder 120 181	increased-risk ALL or stage III and IV lymphoblastic lymphoma
T18	Drug 65 68	MTX
T19	Route 73 95	intrathecal injections
T20	Route 59 64	HD IV
T21	Drug 99 102	MTX
T14	Potential_therapeutic_event 0 10	Prevention
T17	Combination 69 72	and
E1	Potential_therapeutic_event:T14 arg:T12 arg2:T11
E2	Combination:T17 arg:T21 arg2:T18
T1	Potential_therapeutic_event 182 189	treated
E3	Potential_therapeutic_event:T1 arg:T11 arg2:T2
T2	Treatment 195 268	our BFM-based treatment protocol in which cranial irradiation was omitted
T3	Treat-Disorder 120 181	increased-risk ALL or stage III and IV lymphoblastic lymphoma
R1	has Arg1:T12 Arg2:T15	
R2	has Arg1:T2 Arg2:T3	
R3	has Arg1:T11 Arg2:T16	
R4	has Arg1:T11 Arg2:T10	
R5	has_child Arg1:E1 Arg2:E2	
